虽然削弱经济已迫使一些制药公司取消或推迟一些临床项目的早期阶段,但至少一个公司已经看到,越来越需要有其特殊的临床一期的药物开发服务。
While the weakening economy has forced some drug companies to cancel or delay early phase projects, at least one company has seen a growing need for its niche phase I drug development services.
虽然削弱经济已迫使一些制药公司取消或推迟一些临床项目的早期阶段,但至少一个公司已经看到,越来越需要有其特殊的临床一期的药物开发服务。
While the weakening economy has forced some drug companies to cancel or delay early phase projects, at least one company has seen a growing need for its niche phase I drug development services.
应用推荐